Sales & Marketing News | pharmaphorum

News

Merck's SpringWorks takeover delivers a drug approval

Merck gets another quick return on its $3.9bn SpringWorks takeover with EU approval of Ezmekly for tumours caused by neurofibromatosis type 1.

News

A woman holds her hands up in a signal of 'No'

Sarepta resists as FDA seeks pause on Elevidys use

Sarepta has defied an FDA request to halt all use of its gene therapy for Duchenne muscular dystrophy, creating an intriguing regulatory impasse.

News

BMS, Pfizer take DTC route for blood thinner Eliquis

BMS, Pfizer launch direct-to-patient sales for anticoagulant Eliquis, as a report cites conflict-of-interest concerns about the emerging DTC channel.

News

GSK's growth plans dented by Blenrep setback

FDA advisors have voted that the benefit/risk profile of GSK's multiple myeloma therapy, Blenrep, does not support its approval in the US.

News

Colleagues discuss information on a laptop screen

EVERSANA unveils new AI-powered pharmacovigilance suite

EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.

News

Bayer extends CEO contract amid 'signs of success'

Bayer's chief executive Bill Anderson looks set to keep his role until nearly the decade, as his turnaround plan starts to deliver results.

Merck's SpringWorks takeover delivers a drug approval

Sarepta resists as FDA seeks pause on Elevidys use

BMS, Pfizer take DTC route for blood thinner Eliquis

GSK's growth plans dented by Blenrep setback

EVERSANA unveils new AI-powered pharmacovigilance suite

Bayer extends CEO contract amid 'signs of success'

Compounded tirzepatide recalled after FDA warning

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks